As hyperphosphorylated tau is secreted from neurons in response to Aβ plaques, total tau (t-tau) and phosphorylated tau (p-tau) levels increase in both the CSF and plasma of AD patients [2,7,8]. The gene discussed is MAPT; the disease is Alzheimer disease.